Abstract:ABCB1 is a promising therapeutic target for overcoming multidrug resistance (MDR). In this work, we reported the structure-based design of triazolo[1,5-a]pyrimidines as new ABCB1 modulators, of which WS-691 significantly increased sensitization of ABCB1-overexpressed SW620/Ad300 cells to paclitaxel (PTX) (IC50 = 22.02 nM). Mechanistic studies indicated that WS-691 significantly increased the intracellular concentration of PTX and [3H]-PTX while decreasing the efflux of [3H]-PTX in SW620/Ad300 cells by inhibiting the efflux function of ABCB1. The cellular thermal shift assay suggested that WS-691 could stabilize ABCB1 by directly binding to ABCB1. WS-691 could stimulate the activity of ABCB1 ATPase but had almost no inhibitory activity against CYP3A4. Importantly, WS-691 increased the sensitivity of SW620/Ad300 cells to PTX in vivo without observed toxicity. Collectively, WS-691 is a highly potent and orally active ABCB1 modulator capable of overcoming MDR. The triazolo[1,5-a]pyrimidine may be a promising scaffold for developing more potent ABCB1 modulators.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01741?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01741</a>.Cell survival rates under the nontoxic concentration of compounds toward selected cancer cells NMR, HRMS, and HPLC spectra of compounds 5–55 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01741/suppl_file/jm0c01741_si_001.pdf">PDF</a>)Coordinates of modeled structures in PDB format: WS-36 in complex with ABCB1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Q9H">4Q9H</a>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01741/suppl_file/jm0c01741_si_002.pdb">PDB</a>)Coordinates of modeled structures in PDB format: WS-691 in complex with ABCB1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Q9H">4Q9H</a>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01741/suppl_file/jm0c01741_si_003.pdb">PDB</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01741/suppl_file/jm0c01741_si_004.csv">CSV</a>)This article has not yet been cited by other publications.

Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5- a ]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators

Discovery of the Triazolo[1,5- a ]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance

Discovery of a Non-Toxic [1,2,4]Triazolo[1,5-A]pyrimidin-7-one (WS-10) That Modulates ABCB1-mediated Multidrug Resistance (MDR).

Cell-Based Screen Identifies a Highly Potent and Orally Available ABCB1 Modulator for Treatment of Multidrug Resistance

Exploration of 1,2,3-Triazole-pyrimidine Hybrids As Potent Reversal Agents Against ABCB1-mediated Multidrug Resistance

Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance

Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[ h ]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer

Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance

Synthesis and Biological Evaluation of JL-A7 Derivatives As Potent ABCB1 Inhibitors.

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety As Orally Bioavailable Reversal Agents Against P-Glycoprotein-Mediated Mutidrug Resistance.

Design, Synthesis and Biological Evaluation of Biaryl Amide Derivatives As Modulators of Multi-Drug Resistance

Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors

Pharmacophore‐Based Drug Design and Biological Evaluation of Novel ABCB1 Inhibitors

Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance

Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters

2-Trifluoromethyl-2-Hydroxypropionamide Derivatives as Novel Reversal Agents of ABCG2 (BCRP)-Mediated Multidrug Resistance: Synthesis and Biological Evaluations

Imidazo[1,2-a]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Resistance

Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells

Sensitization of Abcb1 Overexpressing Cells to Chemotherapeutic Agents by Fg020326 Via Binding to Abcb1 and Inhibiting Its Function

Abstract 1740: Analogs of OSI-930 As Potent ABCG2-mediated Multidrug Resistance Reversal Agents